Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VTP50469 |
| Trade Name | |
| Synonyms | VTP 50469|VTP-50469 |
| Drug Descriptions |
VTP50469 inhibits the MEN1-KMT2A interaction, which potentially leads to decreased tumor growth (PMID: 31821784). |
| DrugClasses | MEN1-KMT2A Inhibitor 8 |
| CAS Registry Number | 2169916-18-9 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Gilteritinib + VTP50469 | Gilteritinib VTP50469 | 0 | 0 |
| Ponatinib + VTP50469 | Ponatinib VTP50469 | 0 | 0 |
| Quizartinib + VTP50469 | Quizartinib VTP50469 | 0 | 0 |
| VTP50469 | VTP50469 | 0 | 0 |